The dipeptidyl peptidase-4 inhibitor-sitagliptin modulates calcium dysregulation, inflammation, and PPARs in hypertensive cardiomyocytes

Medicine and Dentistry

• Isotopes of Calcium 100%
• Sitagliptin 100%
• Peroxisome Proliferator Activated Receptor 100%
• Dipeptidyl Peptidase-4 Inhibitor 100%
• Cardiac Muscle Cell 100%
• Spontaneously Hypertensive Rat 75%
• Calcium Ion 62%
• Protein Expression 37%
• Receptor 37%
• Angiotensin II 37%
• Tumor Necrosis Factor 25%
• Ryanodine Receptor 25%
• Receptor Protein 25%
• Cav1.2 25%
• Cytokine 12%
• Microelectrode 12%
• Sarcoplasmic reticulum 12%
• Adenosine Triphosphatase 12%
• Homeostasis 12%
• Sodium Ion 12%
• Action Potential Duration 12%
• Arrhythmogenesis 12%
• Western Blot 12%
• Antidiabetic Agent 12%
• Potassium Current 12%
• Interleukin 6 Receptor 12%
• QT Prolongation 12%
• Interleukin 6 12%
• Action Potential 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Sitagliptin 100%
• Peroxisome Proliferator Activated Receptor 100%
• Dipeptidyl Peptidase IV Inhibitor 100%
• Inflammation 100%
• Spontaneously Hypertensive Rat 75%
• Calcium Ion 62%
• Receptor 37%
• Angiotensin II 37%
• Tumor Necrosis Factor 25%
• Receptor Protein 25%
• Ryanodine Receptor 25%
• Western Blot 12%
• Arrhythmogenesis 12%
• Cytokine 12%
• Anti-Inflammation 12%
• Antidiabetic Agent 12%
• Wistar Kyoto Rat 12%
• Adenosine Triphosphatase 12%
• QT Prolongation 12%
• Sodium Ion 12%
• Interleukin 6 Receptor 12%
• Interleukin 6 12%
• Isotopes of Potassium 12%